Overview

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

Status:
Completed
Trial end date:
2006-04-28
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Pioglitazone
Sitagliptin Phosphate
Criteria
Inclusion Criteria:

- Patients at least 18 years of age and not older than 75 who have a specific type of
diabetes called Type 2 Diabetes Mellitus

Exclusion Criteria:

- Younger than 18 years of age or older than 75

- Any condition, which in the opinion of the investigator, may not be in the patient's
best interest to participate